Drug intelligence / Profile preview

chlorhexidine + cymenol

Development stage: Preclinical
Modality: Small Molecules
Administration: Topical, Dental

Overview

Chlorhexidine + cymenol is an antiseptic combination used primarily in dental applications. It combines chlorhexidine, a well-established antiseptic agent, with cymenol (o-cymen-5-ol), which has antimicrobial properties against bacteria and fungi. This combination is formulated as both mouthwash and gel preparations for the treatment of gingivitis and periodontitis. Clinical studies have shown that it demonstrates potent and immediate antimicrobial activity on salivary flora and dental plaque biofilm, with effects lasting up to seven hours after application[1][2].

Beyond the preview

Go deeper on chlorhexidine + cymenol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on chlorhexidine + cymenol.

Explore the full profile